BioVaxys Technology Corp. Enters New Marketing Agreement
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) is excited to announce its recent collaboration with Outside the Box Capital Inc. (OTB) to enhance its marketing strategies. This partnership, undergoing for six months, aims at producing robust marketing and distribution services, fundamentally focusing on increasing company awareness and engagement among potential investors.
Understanding the Marketing Services Agreement
The marketing services agreement outlines a structured approach where OTB will receive an upfront cash fee of $130,000 in return for its extensive service offerings. Notably, BioVaxys will not provide stock or securities under this agreement. The partnership's key elements include:
Strategic Planning and Execute Campaigns
OTB will collaborate with BioVaxys in initial planning phases and conduct ongoing strategy calls. This engagement will encompass feedback sessions, advice, and continuous check-ins, all intended to optimize the marketing campaign's efficiency and effectiveness.
Enhanced Social Media Engagement
In today’s digital age, utilizing social media is crucial for gaining visibility. OTB will drive this aspect by engaging with various community platforms, thereby aiming to boost awareness of BioVaxys's innovative solutions and increase investor engagement.
Comprehensive Distribution of Company Messaging
OTB will take charge of disseminating BioVaxys-approved messages, press releases, and promotional materials across multiple social channels, including popular platforms like Reddit, Discord, and Telegram. This strategic distribution aims at reaching broader audiences and engaging them in the company’s narrative.
Community Involvement and Influencer Engagement
One of the significant methods of outreach will involve connecting with influencers and featuring BioVaxys in various online videos. This tactic is designed to enrich the storytelling around the company’s mission and capture the attention of diverse community members.
Regular Updates Through Videos
OTB will also provide Q&A sessions and highlight videos regarding BioVaxys news. These updates aim to keep the audience informed and engaged, fostering a deeper connection with the company.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. operates as a clinical-stage biopharmaceutical entity committed to advancing patient treatment options through unique immunotherapy solutions. By leveraging its patented DPX™ immune-educating technology platform, the company aims to treat various medical conditions, including cancers and infectious diseases. BioVaxys’s platforms facilitate effective antigen delivery to the immune system, fostering healthy immune responses as evidenced in clinical studies.
Leadership Perspective
The CEO of BioVaxys, James Passin, expresses optimism regarding the new initiatives this agreement will bring about. With a vision focused on patient-centric solutions and technological advancements, he underlines the importance of this collaboration in reaching new market heights.
Next Steps for BioVaxys
As BioVaxys moves forward with this strategic partnership, the focus remains on diligently advancing its clinical programs and ensuring regulatory compliance. The collaboration with OTB is anticipated to elevate the company’s profile significantly, ultimately making a positive impact on its growth trajectory.
Frequently Asked Questions
What services will OTB provide to BioVaxys?
OTB will deliver a wide range of marketing and distribution services, including strategic planning, social media engagement, and messaging distribution.
How long will the marketing agreement last?
The marketing services agreement is expected to last for six months, starting from its commencement date.
What is BioVaxys's core mission?
BioVaxys's core mission revolves around improving patient lives through innovative biopharmaceuticals, specifically utilizing its unique immunotherapy technologies.
Who is responsible for overseeing the marketing campaign?
The campaign will be managed collaboratively by BioVaxys and OTB, with ongoing strategy meetings and feedback sessions ensuring optimal execution.
Where can I learn more about BioVaxys Technology Corp.?
For more information, visit BioVaxys Technology Corp’s official website to explore their services and initiatives.
